Literature DB >> 8480618

Introduction: is hypertension a metabolic disease?

N M Kaplan1, P Weidmann.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8480618     DOI： 10.1016/0002-8703(93)90444-e

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  3 in total

Review 1.  Safety and tolerability of moxonidine in the treatment of hypertension.

Authors:  M Schachter; J Luszick; B Jäger; C Verboom; E Söhlke
Journal:  Drug Saf       Date:  1998-09       Impact factor: 5.606

Review 2.  Race and hypertension. What is clinically relevant?

Authors:  D R Rutledge
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546

3.  Cardiovascular risk and risk reduction: a review of recent literature.

Authors:  T Theodorson
Journal:  J Family Community Med       Date:  1995-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.